Full text is available at the source.
Abstract
Benzalkonium chloride (BAK) is associated with chronic ocular surface toxicity.
- BAK is commonly used in eye treatments.
- It may cause inflammation in the corneal epithelium.
- BAK could disrupt normal cellular recycling processes (autophagy).
- The relationship between inflammation and autophagic impairment is not fully understood.
Simplified